Supplementary Table 1 -A pharmacovigilance study of terbinafine indication and liver enzyme elevation

Name: Supplementary Table 1 -A pharmacovigilance study of terbinafine indication and liver enzyme elevation
Creator: Ivan Litvinov
Published: 2022-07-07T18:56:39.844Z
Keywords: Statistical Table

Litvinov, Ivan

doi:10.17632/n8pkb4tzyz.1

Supplementary Table 1 -A pharmacovigilance study of terbinafine indication and liver enzyme elevation

Published: 7 July 2022| Version 1 | DOI: 10.17632/n8pkb4tzyz.1

Contributor:

Ivan Litvinov

Description

Supplemental Table I. Reporting Numbers according to Age Group and Sex for Both FAERS and CVARO Databases. Details on patient demographics, notably age and sex, of patients reporting LEE events with terbinafine usage.

Files

Institutions

McGill University

Supplementary Table 1 -A pharmacovigilance study of terbinafine indication and liver enzyme elevation

Description

Files

Institutions

Categories

Licence